×

Treating sexual desire disorders with flibanserin

  • US 10,675,280 B2
  • Filed: 05/14/2019
  • Issued: 06/09/2020
  • Est. Priority Date: 10/20/2001
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of treating a female hypoactive sexual desire disorder in a human adult patient, comprising orally administering a therapeutically effective amount of flibanserin to the patient to treat the female hypoactive sexual desire disorder.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×